Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

v3.19.3.a.u2
DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS
3 Months Ended
Nov. 30, 2019
Derivative Liability And Fair Value Measurements [Abstract]  
DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

NOTE 8 – DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

 

The Company recognized a derivative liability related to the purchase price protection clause associated with the Series E private offerings. Additional units would be issued to the unit holder if the Company should issue common stock or the equivalent at a share price less than $7.60. In accordance with ASC 815-10- Derivatives and Hedging we measured the derivative liability using a Monte Carlo pricing model. Accordingly, at the end of each quarterly reporting date, the derivative fair market value is re-measured and adjusted to current market value.

 

Changes in the fair value of the warrant liability were as follows:

 

Fair value – August 31, 2019

 

$ 29,501

 

 

 

 

 

 

Reclass of warrant derivative liability from equity

 

 

 

Change in fair value for the period of warrant derivative liability

 

 

(29,501

)

Fair value –November 30, 2019

 

 

 

 

As of November 30, 2019, there is no derivative liability associated with Series E shares as they no longer meet the criteria for price protection.